Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 180.16 Billion JPY | -53.06% |
| 2023 | 238.82 Billion JPY | 14.91% |
| 2022 | 233.16 Billion JPY | 29.86% |
| 2021 | 160.8 Billion JPY | -3.03% |
| 2020 | 158.28 Billion JPY | 29.86% |
| 2019 | 119.17 Billion JPY | -4.63% |
| 2018 | 132.63 Billion JPY | 1.57% |
| 2017 | 135.07 Billion JPY | -12.42% |
| 2016 | 154.24 Billion JPY | 17.21% |
| 2015 | 142.35 Billion JPY | 21.07% |
| 2014 | 119.75 Billion JPY | 58.75% |
| 2013 | 76.66 Billion JPY | -8.45% |
| 2012 | 50.6 Billion JPY | -9.23% |
| 2011 | 79.11 Billion JPY | -28.85% |
| 2010 | 115.8 Billion JPY | -35.97% |
| 2009 | 180.84 Billion JPY | 18.52% |
| 2008 | 154.11 Billion JPY | 11.91% |
| 2007 | 136.34 Billion JPY | 26.42% |
| 2006 | 95.21 Billion JPY | 69.02% |
| 2005 | 52.91 Billion JPY | -26.8% |
| 2004 | 87.24 Billion JPY | 3.33% |
| 2003 | 79.2 Billion JPY | 22.62% |
| 2002 | 65.98 Billion JPY | 17.44% |
| 2001 | 53.74 Billion JPY | -86.33% |
| 2000 | 428.64 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - JPY | -12.27% |
| 2024 Q1 | 45.06 Billion JPY | -11.6% |
| 2024 Q3 | 59.96 Billion JPY | 3818.37% |
| 2024 Q2 | 54.62 Billion JPY | -103.47% |
| 2024 Q4 | 58.17 Billion JPY | 81.08% |
| 2023 Q2 | 67.42 Billion JPY | 46.63% |
| 2023 Q1 | 45.98 Billion JPY | -28.93% |
| 2023 FY | - JPY | 14.91% |
| 2023 Q4 | 63.09 Billion JPY | -3.15% |
| 2023 Q3 | 65.14 Billion JPY | -3.38% |
| 2022 Q1 | 43.42 Billion JPY | -3.65% |
| 2022 Q3 | 55.53 Billion JPY | -17.62% |
| 2022 Q4 | 64.69 Billion JPY | 16.49% |
| 2022 FY | - JPY | 29.86% |
| 2022 Q2 | 67.41 Billion JPY | 55.24% |
| 2021 Q2 | 40.54 Billion JPY | 108.65% |
| 2021 Q1 | 19.43 Billion JPY | -16.22% |
| 2021 Q4 | 45.07 Billion JPY | -10.02% |
| 2021 FY | - JPY | -3.03% |
| 2021 Q3 | 50.08 Billion JPY | 23.55% |
| 2020 Q2 | 55.64 Billion JPY | 70.22% |
| 2020 FY | - JPY | 29.86% |
| 2020 Q3 | 46.57 Billion JPY | -16.3% |
| 2020 Q4 | 23.19 Billion JPY | -50.2% |
| 2020 Q1 | 32.69 Billion JPY | 37.23% |
| 2019 Q2 | 29.26 Billion JPY | 786.52% |
| 2019 Q1 | 3.3 Billion JPY | -90.8% |
| 2019 Q4 | 23.82 Billion JPY | -27.25% |
| 2019 FY | - JPY | -4.63% |
| 2019 Q3 | 32.74 Billion JPY | 11.9% |
| 2018 Q3 | 36.93 Billion JPY | -2.75% |
| 2018 FY | - JPY | 1.57% |
| 2018 Q1 | 26.5 Billion JPY | -20.05% |
| 2018 Q4 | 35.89 Billion JPY | -2.83% |
| 2018 Q2 | 37.98 Billion JPY | 43.3% |
| 2017 Q3 | 36.75 Billion JPY | 8.19% |
| 2017 Q2 | 33.97 Billion JPY | 27.18% |
| 2017 FY | - JPY | -12.42% |
| 2017 Q1 | 26.71 Billion JPY | -5.66% |
| 2017 Q4 | 33.15 Billion JPY | -9.79% |
| 2016 FY | - JPY | 17.21% |
| 2016 Q2 | 28.74 Billion JPY | 53.87% |
| 2016 Q1 | 18.68 Billion JPY | -28.35% |
| 2016 Q4 | 28.31 Billion JPY | 22.85% |
| 2016 Q3 | 23.04 Billion JPY | -19.83% |
| 2015 FY | - JPY | 21.07% |
| 2015 Q2 | 19.06 Billion JPY | 41.16% |
| 2015 Q3 | 20.57 Billion JPY | 7.95% |
| 2015 Q1 | 13.5 Billion JPY | -30.1% |
| 2015 Q4 | 26.07 Billion JPY | 26.72% |
| 2014 Q2 | 17.42 Billion JPY | 192.43% |
| 2014 Q3 | 19.68 Billion JPY | 12.98% |
| 2014 Q4 | 19.31 Billion JPY | -1.86% |
| 2014 FY | - JPY | 58.75% |
| 2014 Q1 | 5.95 Billion JPY | -29.8% |
| 2013 Q2 | 10.77 Billion JPY | 1196.03% |
| 2013 Q4 | 8.48 Billion JPY | 76.92% |
| 2013 Q3 | 4.79 Billion JPY | -55.46% |
| 2013 Q1 | 831 Million JPY | -81.88% |
| 2013 FY | - JPY | -8.45% |
| 2012 Q2 | 13.18 Billion JPY | 223.45% |
| 2012 Q1 | 4.07 Billion JPY | -61.05% |
| 2012 Q3 | 8.83 Billion JPY | -33.04% |
| 2012 Q4 | 4.58 Billion JPY | -48.05% |
| 2012 FY | - JPY | -9.23% |
| 2011 Q1 | 22.8 Billion JPY | -22.55% |
| 2011 Q2 | 22.64 Billion JPY | -0.69% |
| 2011 FY | - JPY | -28.85% |
| 2011 Q4 | 10.46 Billion JPY | -55.43% |
| 2011 Q3 | 23.48 Billion JPY | 3.71% |
| 2010 Q1 | 24.36 Billion JPY | -67.01% |
| 2010 FY | - JPY | -35.97% |
| 2010 Q3 | 33.16 Billion JPY | 15.04% |
| 2010 Q4 | 29.44 Billion JPY | -11.2% |
| 2010 Q2 | 28.82 Billion JPY | 18.31% |
| 2009 FY | - JPY | 18.52% |
| 2009 Q4 | 73.85 Billion JPY | 72.0% |
| 2009 Q3 | 42.93 Billion JPY | 33.62% |
| 2009 Q2 | 32.13 Billion JPY | 0.67% |
| 2009 Q1 | 31.92 Billion JPY | 0.0% |
| 2008 FY | - JPY | 11.91% |
| 2007 FY | - JPY | 26.42% |
| 2006 FY | - JPY | 69.02% |
| 2005 FY | - JPY | -26.8% |
| 2004 FY | - JPY | 3.33% |
| 2003 FY | - JPY | 22.62% |
| 2002 FY | - JPY | 17.44% |
| 2001 FY | - JPY | -86.33% |
| 2000 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 18689995.991% |
| Ansell Limited | 209.86 Million USD | -85748.125% |
| Ansell Limited | 206.3 Million USD | -87230.102% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -420448.162% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 11087326.63% |
| Psykey, Inc. | -1.29 Million USD | 13908958.461% |
| ConvaTec Group Plc | 455.5 Million USD | -39452.58% |
| ConvaTec Group Plc | 455.5 Million USD | -39452.58% |
| Encision Inc. | -544.19 Thousand USD | 33106247.613% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 127044737.191% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 163888028.682% |
| Innovative MedTech Inc. | -7.67 Million USD | 2347849.497% |
| LifePoint, Inc. | -14.2 Million USD | 1268655.57% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 2912044.4% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 55434561.538% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 83705276.691% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 44398597.723% |
| SmileDirectClub, Inc. | -186.13 Million USD | 96888.959% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -40130.503% |
| SheerVision, Inc. | -110.53 Thousand USD | 162996906.326% |
| United Health Products, Inc. | -2.5 Million USD | 7200203.588% |
| Vasamed, Inc. | -4.57 Million USD | 3938547.575% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 7969274.64% |
| Yubo International Biotech Limited | -1.17 Million USD | 15298065.672% |